✦ LIBER ✦

The dark side of platelet glycoprotein IIb/IIIa receptor inhibitors during percutaneous coronary interventions

✍ Scribed by Lloyd W. Klein; James E. Calvin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trials of platelet glycoprotein IIb/IIIa

✍ A.Michael Lincoff 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 99 KB

Should glycoprotein IIb/IIIa inhibitors

✍ J. E. Exaire; A. M. Lincoff 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

Should glycoprotein IIb/IIIa inhibitors

✍ M. Ragosta; I. J. Sarembock 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Exit of platelet glycoprotein-IIb/IIIa-r

✍ Marc Verstraete 📂 Article 📅 2001 🏛 The Lancet 🌐 English ⚖ 44 KB

Exit of platelet glycoprotein-IIb/IIIa-r

✍ Philip C Adam; James Pemberton; Keith L Evemy 📂 Article 📅 2001 🏛 The Lancet 🌐 English ⚖ 57 KB

Bolus-only versus bolus + infusion of gl

✍ Annapoorna S. Kini; Victor H.T. Chen; Prakash Krishnan; Paul Lee; Michael C. Kim 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 292 KB